News
May 11, 2016Moderate to Severe Alzheimer’s Disease and Available Clinical Trials: A Discussion with Dr. Richard Holub
Dr. Richard Holub is President of the Neurological Associates of Albany Alzheimer’s Research Division and Memory Disorder Unit. The clinical arm of Neurological Associates of Albany currently has a panel of over 2,000 patients and provides comprehensive neurological services to over 1,000 patients diagnosed with Alzheimer’s disease, MCI, or other forms of dementia.
In addition to providing high quality neurological care, Dr. Holub is also the principal investigator for the research division of NAA, where he has been conducting phase II and phase III clinical trials for over 30 years. Dr. Holub has conducted over 125 successful clinical trials and has played a significant role in the investigation of all five drugs currently approved by the FDA for the treatment of Alzheimer’s disease.
If you’d like to learn more about moderate to severe Alzheimer’s disease and how it affects you and your entire family, please consider attending this FREE event on Tuesday, May 17 from 6:30 to 7:30 p.m. at Baptist Health Nursing & Rehabilitation Center, 297 N. Ballston Ave in Scotia. Refreshments will be served.
